These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28778748)

  • 1. The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker.
    Guo T; Huang L; Liu C; Shan S; Li Q; Ke L; Cheng B
    Exp Gerontol; 2017 Oct; 97():64-67. PubMed ID: 28778748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
    Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease.
    Liu T; Han C; Sun L; Ding Z; Shi F; Wang R; Wang W; Shan W; Zhang Y; Hu N; Liu J; Bu H
    Coron Artery Dis; 2019 Nov; 30(7):528-535. PubMed ID: 31464731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity C-Reactive Protein to HDL-C Ratio.
    Luo H; Kou T; Yin L
    Int Heart J; 2021 Nov; 62(6):1221-1229. PubMed ID: 34744148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease.
    Haybar H; Assareh A; Ghotbi Y; Torabizadeh M; Bozorgmanesh M
    Heart; 2013 May; 99(9):640-8. PubMed ID: 23468517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
    Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
    J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood count parameters can predict the severity of coronary artery disease.
    Uysal HB; Dağlı B; Akgüllü C; Avcil M; Zencir C; Ayhan M; Sönmez HM
    Korean J Intern Med; 2016 Nov; 31(6):1093-1100. PubMed ID: 27052265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of inflammatory parameters pentraxin-3, cyclophilin and heparin-binding epidermal growth factor-like growth factor in patients with ST-elevation myocardial infarction.
    Vuković Dejanović V; Bogavac-Stanojević N; Kotur Stevuljević J; Vukašinović A; Stefanović A; Kafedzic S; Zdravković M; Ilić I; Hinić S; Cerović M; Stefanović M; Spasojević-Kalimanovska V; Memon L; Nešković AN
    Scand J Clin Lab Invest; 2020 Feb; 80(1):66-72. PubMed ID: 31799884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential value of Copeptin and Pentraxin3 for evaluating the severity of coronary stenosis in patients with coronary artery disease.
    Cao RY; Yang J; Zheng Y; Li H; Zhao Q; Ding Y; Li Q; Liu S; Wang L; Zheng H
    Clin Biochem; 2021 Jan; 87():32-38. PubMed ID: 33080253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between pentraxin 3 and severity of coronary artery disease.
    Liu H; Guan S; Fang W; Yuan F; Zhang M; Qu X
    BMJ Open; 2015 Apr; 5(4):e007123. PubMed ID: 25854969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
    Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease.
    Akboga MK; Canpolat U; Yayla C; Ozcan F; Ozeke O; Topaloglu S; Aras D
    Angiology; 2016 Jan; 67(1):89-95. PubMed ID: 25922197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of coronary artery disease: a Gensini score assessment.
    Chen J; Chen MH; Li S; Guo YL; Zhu CG; Xu RX; Zhang Y; Sun J; Qing P; Liu G; Li JJ
    J Atheroscler Thromb; 2014; 21(12):1271-82. PubMed ID: 25069816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
    Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography.
    Sari I; Sunbul M; Mammadov C; Durmus E; Bozbay M; Kivrak T; Gerin F
    Kardiol Pol; 2015; 73(12):1310-6. PubMed ID: 25987404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulation levels of acute phase proteins pentraxin 3 and serum amyloid A in atherosclerosis have correlations with periodontal inflamed surface area.
    Temelli B; Yetkin Ay Z; Savaş HB; Aksoy F; Kumbul Doğuç D; Uskun E; Varol E
    J Appl Oral Sci; 2018; 26():e20170322. PubMed ID: 29742255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3 (PTX3) promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease.
    Guo TM; Huang LL; Liu K; Ke L; Luo ZJ; Li YQ; Chen XL; Cheng B
    J Geriatr Cardiol; 2016 Aug; 13(8):712-717. PubMed ID: 27781062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.